In addition to the near-universal TP53 and RB1 mutations observed in SCLC genomes [8], transcriptomic analyses have prompted the development of a ‘molecular taxonomy’ or molecular subtypes of SCLCs defined by lineage-specific transcription factors and regulators. The gene discussed is TP53; the disease is small cell lung carcinoma.